Xanthine mimetics as potent dipeptidyl peptidase IV inhibitors-Reference-Cited by-同舟云学术

Xanthine mimetics as potent dipeptidyl peptidase IV inhibitors

Published:2006-12 Issue:24 Volume:16 Page:6226-6230
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Kurukulasuriya Ravi,Rohde Jeffrey J.,Szczepankiewicz Bruce G.,Basha Fatima,Lai Chunqui,Jae Hwan-Soo,Winn Martin,Stewart Kent D.,Longenecker Kenton L.,Lubben Thomas W.,Ballaron Stephen J.,Sham Hing L.,von Geldern Thomas W.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference17 articles.

1. The GLP‐1 system as a therapeutic target

2. GIP as a Potential Therapeutic Agent?

3. Insulinotropic glucagon-like peptide I receptor expression in glucagon-producing alpha-cells of the rat endocrine pancreas

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Long-Acting Dipeptidyl Peptidase-4 Inhibitors: Structural Evolution and Long-Acting Determinants;Journal of Medicinal Chemistry;2023-08-30

2. Fused azoloazines with antidiabetic activity;Russian Chemical Bulletin;2022-12

3. A review upon medicinal perspective and designing rationale of DPP-4 inhibitors;Bioorganic & Medicinal Chemistry;2021-09

4. Dipeptidyl Peptidase 4 Inhibitors;Burger's Medicinal Chemistry and Drug Discovery;2021-04-26

5. A survey of applications of tetrahydropyrrolo-3,4-azoles and tetrahydropyrrolo-2,3-azoles in medicinal chemistry;Advances in Heterocyclic Chemistry;2020